Ensoma
PrivateLast Round
Financing
Sep 22, 2025
Total Funding Raised
$205M
Company Overview
Ensoma is a biotechnology company that develops in vivo genomic medicine to engineer blood and immune cells for disease treatment using innovative vectors for direct gene modification.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ensoma Comps
Public and private peers based on sector, stage, and business model.
Ensoma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Financing | Sep 22, 2025 | ||||
| Series B Extension | May 16, 2023 | ||||
| Series B | Jan 5, 2023 | ||||
| Series A | Feb 11, 2021 |
Ensoma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SymBiosis Capital Management | Series B Extension, Series B |
| Mirae Asset | Series B |
| Bioluminescence Ventures | Series B, Series B Extension |
| F-Prime Capital | Series A, Series B |
| Arix Bioscience | Series B Extension, Series B |
| 5AM Ventures | Financing, Series A, Series B |
| Cormorant Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 3, 2025
Presenting new preclinical data at the Society for Immunotherapy of Cancer Annual Meeting.
Ensoma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ensoma's valuation, stock price, and market status.
